Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease"

Circulation. 2023 Apr 18;147(16):1258-1259. doi: 10.1161/CIRCULATIONAHA.123.064048. Epub 2023 Apr 17.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Atherosclerosis* / drug therapy
  • Cardiovascular Diseases* / drug therapy
  • Humans
  • Patients

Substances

  • evolocumab
  • Antibodies, Monoclonal, Humanized